These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 921933

  • 21. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
    Pallavicini MG, Gray JW, Folstad LJ.
    Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956
    [Abstract] [Full Text] [Related]

  • 22. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D, Herrick D, Crumpacker C, Schnipper L.
    Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
    [Abstract] [Full Text] [Related]

  • 23. Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.
    Streifel JA, Howell SB.
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5132-6. PubMed ID: 6975478
    [Abstract] [Full Text] [Related]

  • 24. Effects of araC and aphidicolin on DNA chain elongation rate in HeLa S3 cells.
    Wist E.
    Experientia; 1980 Apr 15; 36(4):405-6. PubMed ID: 6769693
    [Abstract] [Full Text] [Related]

  • 25. Replication intermediates formed during initiation of DNA synthesis in methotrexate-resistant CHOC 400 cells are enriched for sequences derived from a specific, amplified restriction fragment.
    Burhans WC, Selegue JE, Heintz NH.
    Biochemistry; 1986 Jan 28; 25(2):441-9. PubMed ID: 3006761
    [Abstract] [Full Text] [Related]

  • 26. Correlation of cytotoxicity with incorporation of ara-C into DNA.
    Kufe DW, Major PP, Egan EM, Beardsley GP.
    J Biol Chem; 1980 Oct 10; 255(19):8997-900. PubMed ID: 7410404
    [Abstract] [Full Text] [Related]

  • 27. Effects of DNA replication inhibitors on UV excision repair in synchronised human cells.
    Downes CS, Collins AR.
    Nucleic Acids Res; 1982 Sep 11; 10(17):5357-68. PubMed ID: 7145704
    [Abstract] [Full Text] [Related]

  • 28. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA.
    Cancer Res; 1992 Nov 15; 52(22):6270-8. PubMed ID: 1423273
    [Abstract] [Full Text] [Related]

  • 29. Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-beta-D-arabinofuranosylcytosine.
    Horber DH, von Ballmoos P, Schott H, Schwendener RA.
    Br J Cancer; 1995 Nov 15; 72(5):1067-73. PubMed ID: 7577448
    [Abstract] [Full Text] [Related]

  • 30. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
    Grem JL, Geoffroy F, Politi PM, Cuddy DP, Ross DD, Nguyen D, Steinberg SM, Allegra CJ.
    Mol Pharmacol; 1995 Aug 15; 48(2):305-15. PubMed ID: 7651364
    [Abstract] [Full Text] [Related]

  • 31. Evidence for double replication of chromosomal DNA segments as a general consequence of DNA replication inhibition.
    Woodcock DM, Cooper IA.
    Cancer Res; 1981 Jun 15; 41(6):2483-90. PubMed ID: 7237443
    [Abstract] [Full Text] [Related]

  • 32. Synthesis of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C) and comparison of its anticancer activity with that of ara-C.
    Tiwari KN, Shortnacy-Fowler AT, Cappellacci L, Parker WB, Waud WR, Montgomery JA, Secrist JA.
    Nucleosides Nucleotides Nucleic Acids; 2000 Jun 15; 19(1-2):329-40. PubMed ID: 10772718
    [Abstract] [Full Text] [Related]

  • 33. Studies on the mechanism of action of cytosine arabinoside.
    Kufe DW, Major PP.
    Med Pediatr Oncol; 1982 Jun 15; 10 Suppl 1():49-67. PubMed ID: 6761569
    [Abstract] [Full Text] [Related]

  • 34. Mode of inhibition of DNA replication in neocarzinostatin-treated HeLa cells.
    Hatayama T, Yukioka M.
    Biochim Biophys Acta; 1983 Aug 02; 740(3):291-9. PubMed ID: 6223664
    [Abstract] [Full Text] [Related]

  • 35. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S, Turner A, Nelms P, Yanovich S.
    Leukemia; 1995 May 02; 9(5):808-14. PubMed ID: 7769843
    [Abstract] [Full Text] [Related]

  • 36. An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents.
    Abdel-Aziz W, Hickey RJ, Malkas LH.
    Biochem Pharmacol; 2004 Jul 01; 68(1):11-21. PubMed ID: 15183113
    [Abstract] [Full Text] [Related]

  • 37. Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.
    Major PP, Egan EM, Beardsley GP, Minden MD, Kufe DW.
    Proc Natl Acad Sci U S A; 1981 May 01; 78(5):3235-9. PubMed ID: 6942429
    [Abstract] [Full Text] [Related]

  • 38. Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
    Horber DH, Schott H, Schwendener RA.
    Br J Cancer; 1995 May 01; 71(5):957-62. PubMed ID: 7734320
    [Abstract] [Full Text] [Related]

  • 39. Effect of cytosine arabinoside on replicon initiation in human lymphoblasts.
    Fridland A.
    Biochem Biophys Res Commun; 1977 Jan 10; 74(1):72-8. PubMed ID: 836288
    [No Abstract] [Full Text] [Related]

  • 40. In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.
    Momparler RL, Goodman J, Karon M.
    Cancer Res; 1975 Oct 10; 35(10):2853-7. PubMed ID: 50882
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.